Vident Investment Advisory’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,692
Closed -$439K 207
2023
Q2
$439K Sell
5,692
-20,122
-78% -$1.56M 0.02% 739
2023
Q1
$1.94M Buy
25,814
+1,601
+7% +$119K 0.06% 350
2022
Q4
$1.91M Sell
24,213
-1,614
-6% -$121K 0.07% 308
2022
Q3
$1.56M Sell
25,827
-92,703
-78% -$7.27M 0.05% 442
2022
Q2
$9.5M Buy
118,530
+23,499
+25% +$1.84M 0.28% 84
2022
Q1
$7.2M Buy
95,031
+729
+0.8% +$57.7K 0.19% 125
2021
Q4
$8.05M Buy
94,302
+19,463
+26% +$1.52M 0.21% 101
2021
Q3
$5.66M Buy
74,839
+14,536
+24% +$1.15M 0.17% 120
2021
Q2
$4.91M Buy
60,303
+16,170
+37% +$1.32M 0.15% 130
2021
Q1
$3.48M Buy
44,133
+8,963
+25% +$703K 0.12% 158
2020
Q4
$3.01M Sell
35,170
-829
-2% -$68.5K 0.12% 139
2020
Q3
$2.78M Buy
35,999
+17,800
+98% +$1.36M 0.14% 129
2020
Q2
$1.33M Sell
18,199
-8,041
-31% -$571K 0.07% 377
2020
Q1
$1.74M Buy
26,240
+16,435
+168% +$1.16M 0.11% 213
2019
Q4
$675K Sell
9,805
-345
-3% -$23.5K 0.04% 471
2019
Q3
$746K Buy
10,150
+342
+3% +$24.8K 0.07% 227
2019
Q2
$703K Sell
9,808
-1,658
-14% -$118K 0.06% 230
2019
Q1
$786K Sell
11,466
-2,168
-16% -$140K 0.04% 463
2018
Q4
$812K Buy
13,634
+732
+6% +$45.8K 0.05% 462
2018
Q3
$864K Sell
12,902
-1,310
-9% -$87.3K 0.03% 512
2018
Q2
$921K Sell
14,212
-612
-4% -$40K 0.04% 446
2018
Q1
$1.07M Buy
14,824
+1,593
+12% +$115K 0.04% 383
2017
Q4
$998K Buy
13,231
+1,440
+12% +$105K 0.04% 377
2017
Q3
$859K Buy
+11,791
New +$850K 0.05% 382
2015
Q4
Sell
-68
Closed -$4K 455
2015
Q3
$4K Sell
68
-362
-84% -$23.6K ﹤0.01% 887
2015
Q2
$28K Buy
+430
New +$29.2K ﹤0.01% 912

Other funds holding CL

Vident Investment Advisory's CL Position: Q3 2023 in Review

Vident Investment Advisory sold out of Colgate-Palmolive (CL) in Q3 2023, closing a stake of 5,692 shares — an estimated $439K sold.

Vident Investment Advisory first reported a position in CL in Q2 2015 and held it in 26 quarters. The position peaked at $9.5M in Q2 2022. 1,620 funds tracked by Wall St. Rank hold CL as of Q3 2023.

  • Vident Investment Advisory reported no remaining Colgate-Palmolive position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 5,692 Colgate-Palmolive shares in Q3 2023, an estimated $439K.
  • Vident Investment Advisory first reported a position in Colgate-Palmolive in Q2 2015 and held it in 26 quarters.
  • Vident Investment Advisory's Colgate-Palmolive position peaked at $9.5M in Q2 2022.
  • 1,620 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.